Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07606625 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study title expanded, about 9 wordsv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to examine the impact of nasal spray treatment on Meibomian gland function and ocular surface health in symptomatic dry eye patients with mild to moderate Meibomian gland dysfunction (MGD).
Trial Details
NCT Number NCT07606625
Lead Sponsor University of California, Berkeley
Collaborators: Viatris Inc.
Conditions
(from sponsor)		 Dry Eye, Meibomian Gland Dysfunction
Related terms Dry Eye Syndromes, Lacerations, Meibomian Gland Dysfunction
Enrollment 65 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov